Aveta Biomics, Inc. — Form D
Aveta Biomics, Inc. of BEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-23. The offering totals $5.0M, of which $600K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-23
- Form: D
- Accession: 0001734691-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $600K
- Remaining: $4.4M
- Investors: 13
- Date of first sale: 2022-02-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-434695
Issuer
- Name: Aveta Biomics, Inc.
- CIK: 0001734691
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 110 GREAT ROAD, SUITE 302, BEDFORD, MA, 01730
- Phone: 339-927-5994
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Guha Bala | Director | Bedford, MA |
| S. P. Kothari | Director | Bedford, MA |
| Parag Mehta | Director | Bedford, MA |
| Parag Mehta | Executive Officer | Bedford, MA |
| Bharat Tewarie | Director | Bedford, MA |
| Peter Dolan | Director | Bedford, MA |
| David Page | Director | Bedford, MA |
| Sharmila Mudgal | Director | Bedford, MA |
| Sharmila Mudgal | Executive Officer | Bedford, MA |
| SP Kothari | Director | Bedford, MA |
Other filings by this issuer (2)
More